Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Federico Mucci, Alessandra Della Vecchia, Stefano Baroni & Donatella Marazziti. (2021) Cariprazine as a therapeutic option for schizophrenia: a drug evaluation. Expert Opinion on Pharmacotherapy 22:4, pages 415-426.
Read now
Read now
Ilaria Cuomo, Georgios D Kotzalidis, Simone de Persis, Daria Piacentino, Filippo Perrini, Emanuela Amici & Sergio De Filippis. (2018) Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of life. Neuropsychiatric Disease and Treatment 14, pages 1645-1656.
Read now
Read now
Giovanni Martinotti, Laura Orsolini, Michele Fornaro, Roberta Vecchiotti, Domenico De Berardis, Felice Iasevoli, Marta Torrens & Massimo Di Giannantonio. (2016) Aripiprazole for relapse prevention and craving in alcohol use disorder: current evidence and future perspectives. Expert Opinion on Investigational Drugs 25:6, pages 719-728.
Read now
Read now
Thomas Hillemacher, Lorenzo Leggio & Annemarie Heberlein. (2015) Investigational therapies for the pharmacological treatment of alcoholism. Expert Opinion on Investigational Drugs 24:1, pages 17-30.
Read now
Read now
Jonna Levola, Mauri Aalto, Antti Holopainen, Alarcos Cieza & Tuuli Pitkänen. (2014) Health-related quality of life in alcohol dependence: A systematic literature review with a specific focus on the role of depression and other psychopathology. Nordic Journal of Psychiatry 68:6, pages 369-384.
Read now
Read now
Ramakrishna Nirogi, Vishwottam Kandikere, Pradeep Jayarajan, Gopinadh Bhyrapuneni, Ramanatha Saralaya, Nageswararao Muddana & Renny Abraham. (2013) Aripiprazole in an Animal Model of Chronic Alcohol Consumption and Dopamine D2 Receptor Occupancy in Rats. The American Journal of Drug and Alcohol Abuse 39:2, pages 72-79.
Read now
Read now
Panagiotis Oulis & George Konstantakopoulos. (2012) Efficacy and safety of pregabalin in the treatment of alcohol and benzodiazepine dependence. Expert Opinion on Investigational Drugs 21:7, pages 1019-1029.
Read now
Read now
AimeeL. McRae-Clark, MarciaL. Verduin, BryanK. Tolliver, RickeyE. Carter, AmyE. Wahlquist, KathleenT. Brady, JeffreyS. Cluver & Samantha Anderson. (2009) An Open-Label Trial of Aripiprazole Treatment in Dual Diagnosis Individuals: Safety and Efficacy. Journal of Dual Diagnosis 5:1, pages 83-96.
Read now
Read now
Articles from other publishers (27)
Giovanni Martinotti, Stefania Chiappini, Mauro Pettorruso, Alessio Mosca, Andrea Miuli, Francesco Di Carlo, Giacomo D’Andrea, Roberta Collevecchio, Ilenia Di Muzio, Stefano L. Sensi & Massimo Di Giannantonio. (2021) Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature. Brain Sciences 11:7, pages 856.
Crossref
Crossref
Matheus Libarino-Santos, Ana Catherine Gomes de Santana Santos, Elisangela G. Cata-Preta, Thaísa Barros-Santos, Nina Rosa Nunes Brandão, Aurea Lorena Nunes Borges, Renan Santos-Baldaia, André W. Hollais, Marilia A. Baldaia, Laís F. Berro, Eduardo A.V. Marinho, Roberto Frussa-Filho & Alexandre J. Oliveira-Lima. (2020) Role of the treatment environment in the effects of aripiprazole on ethanol-induced behavioral sensitization and conditioned place preference in female mice. Drug and Alcohol Dependence 208, pages 107856.
Crossref
Crossref
Valentina Caricasole, Giuseppe Spagnolo, Ilaria Di Bernardo, Giovanna Cirnigliaro, Eleonora Piccoli & Bernardo Dell'Osso. (2019) Aripiprazole causing false positive urine amphetamine drug screen in an adult patient with bipolar disorder. Comprehensive Psychiatry 94, pages 152126.
Crossref
Crossref
Laura B. Ferguson, R. Adron Harris & Roy Dayne Mayfield. (2018) From gene networks to drugs: systems pharmacology approaches for AUD. Psychopharmacology 235:6, pages 1635-1662.
Crossref
Crossref
Carolina L Haass-Koffler, Kimberly Goodyear, William H Zywiak, Lorenzo Leggio, George A Kenna & Robert M Swift. (2018) Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study. Alcohol and Alcoholism 53:3, pages 268-276.
Crossref
Crossref
Carmen Gimeno, Marisa Luisa Dorado, Carlos Roncero, Nestor Szerman, Pablo Vega, Vicent Balanzá-Martínez & F. Javier Alvarez. (2017) Treatment of Comorbid Alcohol Dependence and Anxiety Disorder: Review of the Scientific Evidence and Recommendations for Treatment. Frontiers in Psychiatry 8.
Crossref
Crossref
Giovanni Camardese, Beniamino Leone, Coco Walstra, Luigi Janiri & Riccardo Guglielmo. 2017. Internet Addiction. Internet Addiction
231
245
.
Idaira Oliva & Matthew J. Wanat. (2016) Ventral Tegmental Area Afferents and Drug-Dependent Behaviors. Frontiers in Psychiatry 7.
Crossref
Crossref
Lotfi Khemiri, Pia Steensland, Joar Guterstam, Olof Beck, Arvid Carlsson, Johan Franck & Nitya Jayaram-Lindström. (2015) The effects of the monoamine stabilizer (-)-OSU6162 on craving in alcohol dependent individuals: A human laboratory study. European Neuropsychopharmacology 25:12, pages 2240-2251.
Crossref
Crossref
Giovanni Camardese, Beniamino Leone, Coco Walstra, Luigi Janiri & Riccardo Guglielmo. 2015. Internet Addiction. Internet Addiction
151
165
.
Carolina L. Haass-Koffler, Lorenzo Leggio & George A. Kenna. (2014) Pharmacological Approaches to Reducing Craving in Patients with Alcohol Use Disorders. CNS Drugs 28:4, pages 343-360.
Crossref
Crossref
Jörgen A. Engel & Elisabet Jerlhag. 2014. Dopamine. Dopamine
201
233
.
Dana Most, Laura Ferguson & R. Adron Harris. 2014. Alcohol and the Nervous System. Alcohol and the Nervous System
89
111
.
Giovanni Martinotti, Marco Di Nicola, Daniela Tedeschi, Antonino Callea, Massimo Di Giannantonio & Luigi Janiri. (2013) Craving Typology Questionnaire (CTQ): A scale for alcohol craving in normal controls and alcoholics. Comprehensive Psychiatry 54:7, pages 925-932.
Crossref
Crossref
Doug Hyun Han, Sun Mi Kim, Jung Eun Choi, Kyung Joon Min & Perry F Renshaw. (2013) Adjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: Clinical and neuroimaging evidence. Journal of Psychopharmacology 27:3, pages 282-291.
Crossref
Crossref
Giovanni Camardese, Luisa De Risio, Marco Di Nicola, Giusy Pizi & Luigi Janiri. (2012) A Role for Pharmacotherapy in the Treatment of “Internet Addiction”. Clinical Neuropharmacology 35:6, pages 283-289.
Crossref
Crossref
Pia Steensland, Ida Fredriksson, Sarah Holst, Kristin Feltmann, Johan Franck, Björn Schilström & Arvid Carlsson. (2012) The Monoamine Stabilizer (-)-OSU6162 Attenuates Voluntary Ethanol Intake and Ethanol-Induced Dopamine Output in Nucleus Accumbens. Biological Psychiatry 72:10, pages 823-831.
Crossref
Crossref
Daniela F. Fukushiro, Luis P. Saito, Elisa Mári-Kawamoto, Tatiana C.F. Aramini, Jacqueline M. Costa, Fabiana S. Josino, Regina A. Uehara & Roberto Frussa-Filho. (2012) Withdrawal from repeated treatment with ethanol induces a protracted decrease in novelty-seeking behavior and enhancement of environmental habituation in mice. Pharmacology Biochemistry and Behavior 101:1, pages 132-137.
Crossref
Crossref
Pia Bäckström, Tiina J. Etelälahti & Petri Hyytiä. (2011) Attenuation of reinforcing and psychomotor stimulant effects of amphetamine by aripiprazole. Addiction Biology 16:1, pages 55-63.
Crossref
Crossref
Yu Liu, Yan-ping Bao, Hong-qiang Sun, Thomas J.R. Beveridge, Su-xia Li, Xiao-lan Di, Fu-de Yang & Lin Lu. (2010) Long-Term Treatment With Aripiprazole on the Waking and Postprandial Urges to Smoke in Chinese Heavy Smokers. Journal of Clinical Psychopharmacology 30:4, pages 373-380.
Crossref
Crossref
Fabiana Benites Vaz de Lima, Régis B Andriolo & Dartiu X da Silveira. (2010) Dopaminergic antagonists for alcohol dependence. Cochrane Database of Systematic Reviews.
Crossref
Crossref
George A. Kenna, Lorenzo Leggio & Robert M. Swift. (2009) A safety and tolerability laboratory study of the combination of aripiprazole and topiramate in volunteers who drink alcohol. Human Psychopharmacology: Clinical and Experimental 24:6, pages 465-472.
Crossref
Crossref
Su-xia Li, Yan Zou, Li-jing Liu, Ping Wu & Lin Lu. (2009) Aripiprazole blocks reinstatement but not expression of morphine conditioned place preference in rats. Pharmacology Biochemistry and Behavior 92:2, pages 370-375.
Crossref
Crossref
Yu Liu, Hong-qiang Sun, Yan-ping Bao, Su-xia Li, Thomas J.R. Beveridge, Xiao-lan Di, Fu-de Yang & Lin Lu. (2009) Subjective, cognitive/psychomotor, and physiological effects of aripiprazole in Chinese light and heavy smokers. Drug and Alcohol Dependence 101:1-2, pages 42-52.
Crossref
Crossref
G Martinotti, M Di Nicola, M Di Giannantonio & L Janiri. (2008) Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. Naltrexone. Journal of Psychopharmacology 23:2, pages 123-129.
Crossref
Crossref
Henry R. Kranzler, Jonathan Covault, Amira Pierucci‐Lagha, Grace Chan, Kara Douglas, Albert J. Arias & Cheryl Oncken. (2008) Effects of Aripiprazole on Subjective and Physiological Responses to Alcohol. Alcoholism: Clinical and Experimental Research 32:4, pages 573-579.
Crossref
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:2.
Crossref
Crossref